ArticleCPT: pharmacometrics & systems pharmacology2023

Population PK/PD modeling of low-density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti-PCSK9 monoclonal antibody.

Ellen Q Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.